Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-08
1997-03-25
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142392, 514255, 514317, 514336, 514342, 514467, 514513, 514547, 514548, 514549, 514642, 514643, 514665, 514676, 544158, 544177, 544374, 544398, 544399, 546248, 546264, 546265, 546339, 548203, 548204, 5483111, 5483151, 5483411, 5483421, 548570, 548572, 549 30, 549 35, 549457, 554 42, 554 43, 554 45, 560147, 564291, 564292, 564503, 564508, A61K 31095, A61K 31395, C07F 938, C07D51320, C07D23302
Patent
active
056145489
ABSTRACT:
Quaternary amine-containing ether lipid analogs of the formula
REFERENCES:
patent: 2086582 (1937-07-01), Taub et al. I
patent: 2087132 (1937-07-01), Taub et al. II
patent: 2108765 (1938-02-01), Damagk
patent: 2209383 (1940-07-01), Bock
patent: 2439969 (1948-04-01), Fourneau, I
patent: 2445393 (1948-07-01), Fourneau, II
patent: 2513747 (1950-07-01), Sailmann et al.
patent: 2606909 (1952-08-01), Blicke
patent: 2689790 (1953-09-01), Mowry et al.
patent: 2950253 (1960-08-01), Kling et al.
patent: 3054678 (1962-09-01), Michener et al.
patent: 3694473 (1972-09-01), Bibl et al. I
patent: 4093714 (1978-06-01), Tolman et al.
patent: 4096278 (1978-06-01), Queille
patent: 4119714 (1978-10-01), Kny et al.
patent: 4159988 (1979-07-01), Eibl et al., II
patent: 4235877 (1980-11-01), Fullerton
patent: 4329302 (1982-05-01), Hanahan et al.
patent: 4426525 (1984-01-01), Hozumi et al.
patent: 4444766 (1984-04-01), Bosies et al.
patent: 4471113 (1984-09-01), MacCoss
patent: 4540521 (1985-09-01), Garst et al.
patent: 4619917 (1986-10-01), Lee et al.
patent: 4661509 (1987-04-01), Gordon et al.
patent: 4816450 (1989-03-01), Bell et al.
patent: 4826823 (1989-05-01), Cook et al.
patent: 4835263 (1989-05-01), Nguyen et al.
patent: 4837023 (1989-06-01), Eibl
patent: 4841039 (1989-06-01), Chu et al.
patent: 4880782 (1989-11-01), Eckstein et al.
patent: 5034394 (1991-07-01), Daluge
patent: 5138045 (1992-08-01), Cook et al.
Aggarwal, "Synthesis and Biological Evaluation of Prodrugs of Zidovudine," J. Med. Chem., 33, 1505-1510 (1990).
Boldanova et al., "Protective effect of Phosphatidylcholine-containing Liposomes in Experimental Toxic Hepatitis", (Vopr. Med. Khim, 32, No. 3 (1986) Chemical Abstracts, 105, p. 67, Abstract No. 35587k (1986).
Chen, "Design and Synthesis of Novel Nucleoside Analogs as Potential Antiviral Agents," Abstract American Assoc. of Pharmaceutical Scientists, Orlando FL., (1993).
Crumpton, "Novel Lipid Analogs with Cytostatic and Cytocidal Activity," Submitted to Anticancer Res., vol. 8, No. 6, pp. 1361-1366 (Nov.-Dec. 1988).
Daniel, "Alkyl-Linked Diglygerides Inhibit Protein Kincase C Activation by Diacylglycerols" Biochemical & Biophysical Res. Comm., 151, 291-97 (Feb. 29, 1988).
Dietzfelbinger, "Cytotoxic and Purging Effects of ET-18-OCH.sub.3 in Human Malignant Lymphoid Cell Lines in Vitro," Abstract 2472, Proceedings of the American Assoc. for Cancer Res., 31, 416 (Mar. 1990).
Fields, "Human Immunodeficiency Virus Induces Phosphorylation of its Cell Surface Receptor," Nature, 333, 278-80 (19 May 1988).
Harada, "Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay," Science, 229, 563-229 (9 Aug. 1985).
Himmelmann, "Studies on the Cross Resistance Pattern of Membrane-Toxic Lipids in Vitro," Abstract 2448, Proceedings of the American Assoc. for Cancer Res., 31, 416 (Mar. 1990).
L. Hsu et al., "Synthesis of Anti-Restricted Pyrimidine Acyclic Nucleosides", Journal of Organic Chemistry, vol. 57, No. 12, pp. 3354-3358, (1992).
B. Kasnar et al., "Synthesis of 2',3'-Dideoxy-and 3'-Azido-2', 3'-Dideoxy-Pyridazine Nucleosides as Potential Antiviral Agents", Nucleosides & Nucleotides, 13(1-3), pp. 459-479, (1994).
Korba, "Use of a Standard Cell Culture Assay to Assess Activities of Nucleoside Analogs Against Hepatitus B Virus Replication" Antiviral Res., 19, 55-70 (1992).
L. Krugner-Higby et al. I, "Membrane-Interactive Phospholipids Inhbiit HIV Type 1-Induced Cell Fusion and Surface gp160/gp120 Binding to Monoclonal Antibody", Aids Research and Human Retroviruses, vol. 11, No. 6, pp. 705-712, (1995).
Krugner-Higby et al., II "Novel Membrane Interactive Ether Lipid Analogs Inhibit HIV-1 Glycoprotein Interaction with CD4+ Cells" Abstract from 32nd Interscience Conf on Antimicrobial Agents and Chemotherapy, Anaheim, 164, (11-14 Oct. 1992).
L. S. Kucera et al., "Activity of Triciribine and Triciribine-5'-Monophosphate Against Human Immunodeficiency Virus Types 1 and 2", Aids Research and Human Retroviruses, vol. 9, No. 4, pp. 307-314, (1993).
Kucera, "Effect of Membrane-Active Ether Lipid (EL) Analogues on Human Immunodefiency Virus Production Measured by Plaque Assay," Annals of the New York Acad. of Sciences, 546-548 (26 Dec. 1990).
Kucera, "Inhibition of Humn Immunodefieiency Virus-1 (HIV-1) by Novel Membrane Interactive Ether Lipids," Abstract No. 2470, Proceedngs of the American Assoc. for Cancer Res., 31, 416 (Mar. 1990).
Kucera, "Inhibition of HIV-1 Plaque Formation by a Novel Class of Membrane-Active Ether Lipid Analogs" International Conference on Aids Abstract No. W.C.O.21, Jun. 4-9, 1989, p. 528.
Kucera, "Investigation on Membrane Active Ether Lipid Analogs that Alter Functional Expression of HIV-1 Induces Glycoproteins and Inhibit Pathogenis," Abstract, Innovations in Theraphy of Human Viral Diseases, Symposium, Research Triangle Park,16, (6-9 Dec. 1992).
L. Kucera et al., "Novel Ether Lipid Analogs of Platelet Activating Factor with Anti-Hepatitis B Virus Activity", (Abstract), ICAAC Orlando, (1994).
Kucera, "Novel Membrane-Interactive Ether Lipid Analogs That Inhibit Infectious HIV-1 Production and Induce Defective Virus Formation," Aids Research and Human Retroviruses, 6, 491-501 (1990).
Marasco et al., "Synthesis and Biological Activity of Novel Quaternary Ammonium Derivatives of Alkylglycerols as Potent Inhibitors of Protein Kincase C", Jour. of Med. Chem., 3 No. 3, pp. 985-992 (Mar. 1990).
Marasco et al., "The Synthesis and Biological Testing of Alkyl Glycerols as Potential Inhibitors of Protein Kinase C" American Assoc. of Pharmaceutical Scientists Abstract, Orlando, FL., (1993).
Marasco, Jr., "The Synthesis and Biological Activity of Novel Alkylglycerol Derivatives as Inhibitors of Protein Kinase C Activity, Neoplastic Cell Growth and HIV-1 Infectivity," Dissertation for Ph. D., Univ. of No. Carolina, Chapel Hill 1990.
Marasco, "The Synthesis, Biological Evaluation, and Structure Activity of Amido Phosphocholines and Related Analogs as Anti-HIV-1 Agents," 6th Conf. on Aids, San Francisco, Abstract, (20-24 Jun. 1990).
Meyer, "In Vitro Evaluation of Phosphocholine and Quaternary Ammonium Containing Lipids as Novel Anti-HIV Agents," J. of Med. Chem., 34, 1377-83 (1991).
Meyer, "Synthesis and Evaluation of Anti-HIV-1 Ether Lipids," AAPS Meeting, Atlanta Abstract N. MN-510, p. S-41, (22-25 Oct. 1989).
Misuya, "Strategies of Antiviral Therapy in Aids, " Nature, 325, 773-78 (1987).
Modest, "Antineoplastic and Antiviral Properties of Ether Lipid Analogs", 15th Intl Cancer Congress, Abstract (16-22 Aug. 1990).
Modest, "Combination Chemotherapy Studies with Antitumor and Antiviral Ether Lipid Analogs," Abstract 2471, Proceedings of the American Assoc. for Cancer Res., 31, 416 Abstract 2471 (Mar. 1990).
E. Modest et al., "Comparison of Cell Kill Induced by Two Ether Lipids in Combination with Hyperthermia", Proceedings of the American Association for Cancer Research; Preclinical Pharmacology Experimental Therapeutics, vol. 31, pp. 416, Abstract 2467, (Mar. 1990).
Modest, "Pharmacological Effects and Anticancer Activity of New Ether Phospholipid Analogs" The Pharmacological Effect of Lipids, III: The Role of Lipids in carcinogenesis and Therapy, (In Press), pp. 330-337 (1989).
Nara, "Simple, Rapid, Quantitative, Syncytium-Forming Microassay for the Detection of Human Immunodeficiency Virus Neutralizing Antibody," Aids Res. and Human Retroviruses, 3, 283-302 (1987).
Noseda, "In Vitro Anitproliferative Activity of Combinations of Ether Lipid Analogues and DNA-interactive Agents Against Human Tumor Cells" Journal of Cancer Research, 48, 1788-1791 (Apr. 1988).
Ostertag, "Induction of Endogenous Virus and of Thymidine Kinase by Bromodeoxyuridine in Cell Cultures Transformed by Friend Virus" Proc. Nat. Acad. Sci. USA, 71, 4980-85 (Dec. 1974).
Pacheco, "Mechanisms of Toxicity of Hepsulfam in Human Tumor Cell Lines," Abstract 2446, Proceedings of the American Assoc. for Cancer Res., 31, 416 (Mar. 1990).
Piantadosi, "Synthesis and Evaluation of Novel Ether Lipid Nucleoside Conjugates for Anti-HIV-1 Activity," J. Med. Chem., 34, 1408-14 (1991).
Small,
Daniel Larry W.
Goz Barry P.
Ishaq Khalid S.
Kucera Louis S.
Marasco, Jr. Canio J.
Higel Floyd D.
Wake Forest University
LandOfFree
Quaternary amine containing ether or ester lipid derivatives and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quaternary amine containing ether or ester lipid derivatives and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quaternary amine containing ether or ester lipid derivatives and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203841